Women with polycystic ovary syndrome (PCOS), one of the commonest endocrine conditions in the human, are more likely than other women to have increased blood pressure, endothelial dysfunction, reduced arterial compliance, central obesity, dyslipidaemia, low grade chronic inflammation, and increased endothelin-1 and homocysteine [1] . A recent meta-analysis found an increased incidence of cardiovascular events in women with PCOS, but did not distinguish between coronary heart disease and stroke and did not consider fatal and non-fatal events separately [2] . The present metaanalysis aimed to quantify the risk of non-fatal stroke and coronary heart disease as separate disease events in women with PCOS compared to healthy women.
Nine studies met the inclusion criteria (see list of included studies here [www.ijc.com/references). Women with PCOS were at increased risk of non-fatal stroke and non-fatal CHD but the odds ratios did not reach statistical significance (OR, 1.61; 95% CI, 0.82-3.15; P = 0.17 and OR, 1.63; 95% CI, 0.96-2.78; P = 0.07, respectively). In the five studies where the average age was more than 45 years old, the risk in PCOS was significantly increased for non-fatal stroke (OR, 1.94; 95% confidence interval, 1.19-3.17) and non-significantly increased in the six studies of CHD (OR, 1.70; 95% confidence interval, 0.92-3.11) (Fig. 1) .
For the three studies where the BMI was similar and the mean age was over 45 in the groups the risk was non-significantly increased for women with PCOS for stroke (OR, 1.67; 95% confidence interval, 0.70-4.02) and for the three studies of CHD (OR, 2.04; 95% confidence interval, 0.60-6.97).
The Newcastle-Ottawa scale suggests that the methodological quality of the included studies was moderate. Funnel plots found that although publication bias cannot be ruled out, the asymmetry observed may be due to the relatively young age of the patients in one study.
Women with PCOS appear to be at increased risk of non-fatal stroke and possibly CHD. Although this study was not designed to investigate mechanism, the higher blood pressure and atherogenic lipid profile in women with PCOS may be contributory. In any case, clinicians and policymakers might focus on screening women with PCOS as soon as it is diagnosed, and focus on applying preventative measures, such as lifestyle interventions, appropriate to reducing the risk of stroke.
Whilst the results of the present meta-analysis did not provide evidence of increased risk of CVD in PCOS entirely independent of BMI, evidence of cardiovascular risk in lean women with PCOS [3] supports the hypothesis of the potential for an independent role of PCOS in CVD, perhaps due to the abdominal obesity in PCOS [5] . Future studies of PCOS should measure waist circumference in order to assess abdominal obesity. Furthermore, many women with PCOS receive treatments (the oral contraceptive pill, antiandrogens, insulin sensitizers or laparoscopic ovarian diathermy) which are likely to modify the risk of later cardiovascular events [4] . Future studies should therefore also assess the impact of these interventions on cardiovascular risk in women with PCOS.
These findings have important implications for disease prevention and screening in women. At present, weight management, changes in dietary composition and exercise should be the primary interventions, although pharmacologic treatment of hypertension, dyslipidaemia or insulin resistance may be required where lifestyle modification proves ineffective.
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